Concepedia

Ken H. Hoo

KH

Statistics

Publications

16

Citations

1.2K

H-Index

14

Active since

1987

Affiliations

Therapure Biopharma (Canada)(Current)

Eli Lilly (United States)

McMaster University

Eli Lilly (United Kingdom)

University of Bristol

Ken H. Hoo is an author at Therapure Biopharma (Canada) specializing in pharmacology, kainate receptors, and molecular neuroscience.

Publications per year

1987–2008

16

Publications

16

A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission

Vernon R. J. Clarke, Barbara A. Ballyk, Ken H. Hoo et al. · Nature · 1997 · 416 citations

Life Sciences, Neurobiology, Neuroscience +14

Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat

Rosa Maria A. Simmons, Dominic L. Li, Ken H. Hoo et al. · Neuropharmacology · 1998 · 172 citations

Life Sciences, Neuroscience, Pharmacology +14

Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia

Michael J. O’Neill, Ann Bond, Paul L. Ornstein et al. · Neuropharmacology · 1998 · 115 citations

Medicine, Neuroscience, Pharmacology +14

Synthesis of Willardiine and 6-Azawillardiine Analogs: Pharmacological Characterization on Cloned Homomeric Human AMPA and Kainate Receptor Subtypes

David E. Jane, Ken H. Hoo, Raj Kamboj et al. · Journal of Medicinal Chemistry · 1997 · 95 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

LY339434, a GluR5 kainate receptor agonist

Ben G. Small, J W Thomas, Mark I. Kemp et al. · Neuropharmacology · 1998 · 45 citations

Medicine, Neuroscience, Pharmacology +12

1–5 of 16